Back to Search Start Over

Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS‐positive variant patients.

Authors :
Bessis, Didier
Bursztejn, Anne‐Claire
Morice‐Picard, Fanny
Capri, Yline
Barbarot, Sébastien
Aubert, Hélène
Bodet, Damien
Bourrat, Emmanuelle
Chiaverini, Christine
Poujade, Laura
Willems, Marjolaine
Rouanet, Jacques
Dompmartin‐Blanchère, Anne
Geneviève, David
Gerard, Marion
Ginglinger, Emmanuelle
Hadj‐Rabia, Smaïl
Martin, Ludovic
Mazereeuw‐Hautier, Juliette
Bibas, Nathalie
Source :
Journal of the European Academy of Dermatology & Venereology. Sep2024, Vol. 38 Issue 9, p1818-1827. 10p.
Publication Year :
2024

Abstract

Background: Data on dermatological manifestations of Costello syndrome (CS) remain heterogeneous and lack in validated description. Objectives: To describe the dermatological manifestations of CS; compare them with the literature findings; assess those discriminating CS from other RASopathies, including cardiofaciocutaneous syndrome (CFCS) and the main types of Noonan syndrome (NS); and test for dermatological phenotype–genotype correlations. Methods: We performed a 10‐year, large, prospective, multicentric, collaborative dermatological and genetic study. Results: Thirty‐one patients were enrolled. Hair abnormalities were ubiquitous, including wavy or curly hair and excessive eyebrows, respectively in 68% and 56%. Acral excessive skin (AES), papillomas and keratotic papules (PKP), acanthosis nigricans (AN), palmoplantar hyperkeratosis (PPHK) and 'cobblestone' papillomatous papules of the upper lip (CPPUL), were noted respectively in 84%, 61%, 65%, 55% and 32%. Excessive eyebrows, PKP, AN, CCPUL and AES best differentiated CS from CFCS and NS. Multiple melanocytic naevi (>50) may constitute a new marker of attenuated CS associated with intragenic duplication in HRAS. Oral acitretin may be highly beneficial for therapeutic management of PPHK. No significant dermatological phenotype–genotype correlation was determined between patients with and without HRAS c.34G>A (p.G12S). Conclusions and Relevance: This validated phenotypic characterization of a large number of patients with CS will allow future researchers to make a positive diagnosis, and to differentiate CS from CFCS and NS. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09269959
Volume :
38
Issue :
9
Database :
Academic Search Index
Journal :
Journal of the European Academy of Dermatology & Venereology
Publication Type :
Academic Journal
Accession number :
179238793
Full Text :
https://doi.org/10.1111/jdv.19996